Services & Solutions

Discovery Services

WuXi AppTec provides pharmaceutical discovery services across the entire spectrum of the drug discovery process. Our pharmaceutical discovery services can be fully integrated to provide a flexible and customized solution for client’s specific project needs.

Lab Testing Division (LTD)

Lab Testing Division (LTD) is comprised of seven business units. LTD's integrated services and solutions in the fields of Chemistry and Biology span from early screening to preclinical development and into clinical sample analysis. Leveraging other established WuXi businesses in MedChem, synthesis and formulation, LTD is well positioned to enable customers to accelerate their discovery processes and empower them to bring new, innovative medicines to patients.

Small Molecule Pharmaceutical Development and Manufacturing (STA)

STA Pharmaceutical Co., Ltd. (STA), a WuXi AppTec company, is a global leading small molecule pharmaceutical development and manufacturing capability and technology platform company serving the life science industry. As a premier Contract Development and Manufacturing Organization (CDMO), STA offers our worldwide partners efficient, flexible and high-quality solutions for small molecule Active Pharmaceutical Ingredients (APIs) and finished dosage forms from preclinical to commercial.

WuXi Biologics (China-based CDMO Services)

WuXi Biologics provides a seamless single-source approach for the discovery, development, characterization and manufacture of mAb, ADC and protein therapeutics. We provide the necessary expertise, quality, capacity and project management to reduce the time-to-clinic and significantly decrease the cost of our customers' drug development efforts.

U.S.-Based Biologics Services

Utilizing a wide variety of in vitro, in vivo, molecular and analytical methodologies, WuXi AppTec’s U.S. based biologics testing services can provide a full breadth of services to help take your biologic from preclinical development all the way through to commercialization.

Cell & Gene Therapy Services

WuXi AppTec’s U.S.-based biologics services feature expert technical and regulatory guidance, as well as a wide range of integrated programs that include comprehensive cGMP manufacturing and testing for gene therapies, cell therapies and gene-mediated cell therapies.

U.S. Medical Device Services

WuXi AppTec is uniquely positioned to support product development from concept to commercialization, with industry leading comprehensive testing programs that help ensure regulatory submission success.

Chemistry Services

WuXi AppTec offers a complete spectrum of chemistry services, all led by experts in their respective fields: from synthetic chemistry to chiral separations, from small molecule to peptide/peptidomimetics, from nucleoside to fluorinated building blocks, from milligram synthesis to kilogram GLP scale-up, and from reagent service to compound management.

Toxicology Services

WuXi AppTec’s toxicology services feature a full-range of in-vivo and in-vitro non-clinical safety evaluation programs. As the uniqueness of each product requires a case-by-case approach, we partner with clients to ensure that all study components meet specific program objectives.

Bioanalytical Services

WuXi AppTec offers comprehensive and FDA/OECD/SFDA GLP-compliant bioanalysis services to support preclinical and clinical development for small molecule drugs, biologics, vaccines and PD biomarkers.

Clinical and Regulatory Services

WuXi AppTec has strong experience in clinical trial management and regulatory affairs consultation; our experts are able to provide in-depth support to help clients bring new drugs and devices to the market smarter and faster.

Genome Center

WuXi Genome Center is a leading global genomic sequencing provider. It offers a complete solution to tackle biological and clinical challenges by combining components of genomics, bioinformatics, disease biology and clinical expertise to advance drug discovery, clinical development, and personalized medicine.

Biological Reagents

Abgent, a WuXi AppTec company, is a leading provider of antibodies and related services for biomedical research and drug discovery. Our competencies lie in the development of high quality antibodies and related reagents for the study of neurodegenerative diseases, stem cells, autophagy, and model organisms. Our antibodies are rigorously validated and optimized to ensure accurate and consistent performance.